Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.
Journal of cancer research and clinical oncology(2017)
Abstract
Patients with SETBP1 hotspot mutations suffered from aggressive disease with rapid evolution and inferior overall survival. Patients with SETBP1 non-hotspot mutations had less aggressive disease and a more favorable prognosis. Diagnostic screens for SETBP1 hotspot mutations may help identifying this dismal patient group and treat them in multicenter clinical studies.
MoreTranslated text
Key words
SETBP1 hotspot mutations,sAML,MDS/MPN,Leukemia-associated genes,Myeloid malignancies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined